Statins are the most commonly prescribed medication for high cholesterol, and their effect on LDL is both large and well-documented. Understanding the actual numbers — how much different statins lower LDL, at what doses, and over what timeframe — helps you have a more informed conversation with your doctor about whether and when medication makes sense.
How Statins Work
Statins inhibit an enzyme called HMG-CoA reductase, which the liver uses to produce cholesterol. When cholesterol production drops, the liver compensates by increasing the number of LDL receptors on its surface — proteins that pull LDL particles out of the bloodstream for processing.
The result is a two-sided effect: less LDL produced, and faster LDL clearance. This is why statins produce LDL reductions that are substantially larger than dietary changes alone.
LDL Reduction by Statin Intensity
Statins are grouped into three intensity categories based on their expected LDL reduction:
| Intensity | Expected LDL reduction | Examples |
|---|---|---|
| Low intensity | Less than 30% | Simvastatin 10mg, Pravastatin 10–20mg, Lovastatin 20mg |
| Moderate intensity | 30–49% | Atorvastatin 10–20mg, Rosuvastatin 5–10mg, Simvastatin 20–40mg |
| High intensity | 50% or more | Atorvastatin 40–80mg, Rosuvastatin 20–40mg |
These percentages translate into substantial absolute reductions for most people with elevated LDL:
| Starting LDL | After moderate-intensity statin | After high-intensity statin |
|---|---|---|
| 160 mg/dL | ~85–110 mg/dL | ~70–85 mg/dL |
| 180 mg/dL | ~95–125 mg/dL | ~80–95 mg/dL |
| 200 mg/dL | ~105–140 mg/dL | ~85–105 mg/dL |
| 220 mg/dL | ~115–154 mg/dL | ~95–115 mg/dL |
For someone starting at LDL 160 — at the lower end of the high range — a moderate-intensity statin can bring LDL to optimal or near-optimal levels. For someone at 200+, high-intensity therapy is typically needed to reach that target.
How Quickly Do Statins Lower LDL?
Statins work relatively fast compared to lifestyle interventions. Most of the LDL reduction occurs within the first 2–4 weeks, with the full effect typically visible by 6–8 weeks.
This is one meaningful difference from dietary changes, which generally require 8–12 weeks to produce measurable LDL reductions. A follow-up lab test is usually scheduled 6–12 weeks after starting a statin to confirm the response.
Do Different Statins Produce Different Results?
Yes. While all statins work through the same mechanism, they differ in potency, half-life, and the degree of LDL reduction at equivalent doses.
Atorvastatin (Lipitor) and rosuvastatin (Crestor) are the most potent and most commonly prescribed. At high doses, these are the only statins that reliably achieve 50%+ LDL reduction.
Simvastatin (Zocor) and pravastatin (Pravachol) are moderate-potency options. Simvastatin's upper dose is limited in practice due to muscle side effect risk at 80mg.
Fluvastatin and pitavastatin are less commonly prescribed but useful in specific situations, including in patients with certain drug interactions.
The choice of statin is typically based on required intensity, tolerability, cost, and drug interactions — not a single best option that applies to everyone.
What Statins Don't Do Well
Triglycerides: Statins produce modest triglyceride reductions — typically 10–20% — but they're not the primary tool for significantly elevated triglycerides. If triglycerides are above 500 mg/dL, other medications (fibrates, omega-3 prescriptions) may be added.
HDL: Statins raise HDL modestly — typically 5–10% — but the effect is smaller and less consistent than their LDL effect.
Non-LDL cardiovascular risk: Statins reduce the risk of cardiovascular events (heart attack, stroke) beyond their LDL-lowering effect, likely through anti-inflammatory mechanisms. This is why they're recommended based on overall cardiovascular risk rather than LDL alone, as covered in what cholesterol level requires medication.
Statins Combined With Lifestyle Changes
An important and often underemphasized point: statins and lifestyle changes work through different mechanisms, and their effects are additive.
Someone on a moderate-intensity statin who also reduces saturated fat, increases soluble fiber, and loses weight may achieve LDL reductions of 50–60% from baseline — substantially more than medication alone. This matters in two directions:
- For people already on statins, lifestyle changes can help reach LDL targets that medication alone doesn't fully achieve
- For people considering statins, a period of structured lifestyle change first establishes a new baseline — meaning any medication added later works from a lower starting point
How much cholesterol can drop in 90 days covers the realistic ceiling of lifestyle-only improvement, which informs how to think about whether medication is needed on top of it.
Common Side Effects
Muscle symptoms are the most frequently reported side effect — aching, weakness, or fatigue in the muscles. This occurs in roughly 5–10% of patients in clinical practice, though large randomized trials show lower rates. In the vast majority of cases, symptoms resolve when the dose is reduced or the statin is switched.
Serious muscle damage (rhabdomyolysis) is rare — occurring in less than 1 in 10,000 patients — and is more associated with high-dose simvastatin, certain drug combinations, and specific genetic variants.
Liver enzyme elevation was a significant concern with older statins but is uncommon with modern versions at standard doses. Routine liver monitoring is no longer recommended for most patients on statins.
Diabetes risk: Long-term statin use is associated with a small increased risk of type 2 diabetes — approximately 1 additional case per 100 patients treated over 4 years in high-risk groups. For most patients, the cardiovascular benefit of statin therapy substantially outweighs this risk.
Cognitive effects (memory issues, brain fog) are commonly reported anecdotally but have not been consistently demonstrated in clinical trials. The FDA added a label warning in 2012, but large observational studies have not confirmed a causal relationship.
Non-Statin Medications Worth Knowing
For patients who can't tolerate statins or need additional LDL reduction beyond what statins achieve:
Ezetimibe (Zetia) blocks cholesterol absorption in the intestine. Used alone, it reduces LDL by approximately 15–20%. More commonly used as an add-on to statin therapy, where it produces an additional 20–25% reduction.
PCSK9 inhibitors (evolocumab, alirocumab) are injectable medications that dramatically increase LDL receptor activity. They can reduce LDL by 50–60% on top of statin therapy — producing LDL values below 50 mg/dL in some patients. Currently reserved for very high-risk patients or those with familial hypercholesterolemia due to cost.
Bempedoic acid (Nexletol) inhibits cholesterol synthesis upstream of the statin target and is an option for statin-intolerant patients. It reduces LDL by approximately 15–25%.
The Lifestyle-First Window
For most people with LDL in the 160–189 range and no other major cardiovascular risk factors, clinical guidelines support a 3–6 month structured lifestyle trial before medication is introduced. This isn't indefinite delay — it's a finite window with a clear re-evaluation point.
What's achievable in that window? A consistent combined approach — reducing saturated fat, increasing soluble fiber, losing weight where applicable, and exercising regularly — can reduce LDL by 15–30 mg/dL in many people. For someone starting at 165, that's potentially enough to reach near-optimal without medication.
For the full picture of what drives that improvement, see what affects cholesterol the most and foods that reduce LDL fastest.
If lifestyle changes don't close the gap, statins are a well-studied, highly effective next step — not a failure of effort, but a recognition that genetics and biology set limits that lifestyle can't always overcome.
Free tool
Check your Lipid Score
Tracking the Variables That Inform the Decision
Whether you're in the lifestyle-first window or already on medication, the inputs that affect your LDL — diet quality, fiber intake, weight, activity — continue to matter. Understanding what they're actually doing between lab tests is useful regardless of where you land on the medication question.
LipidLog tracks these daily inputs alongside your lab results, giving you a single score that reflects your full picture between appointments.
Start tracking your progress →
Summary
Statins lower LDL substantially — 30–50% with moderate-intensity therapy, 50%+ with high-intensity therapy — and produce most of that reduction within 6–8 weeks. They are among the most studied medications in history with a well-established safety profile.
Their effect on triglycerides and HDL is smaller than on LDL. They work through a different mechanism than dietary changes, and the two approaches are additive.
For most people with LDL in the high range and no other major risk factors, a structured lifestyle trial is a reasonable first step. Statins are the well-supported next step if that trial doesn't reach the target.